EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer
/PRNewswire/ WHAT: Innovative therapeutic approaches for left ventricular restoration for patients with Heart Failure with Reduced Ejection Fraction (HFrEF)..
/PRNewswire/ BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle.
/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated.
/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated.